- Home
- FENC vs SEVN Comparison
FENC vs SEVN Comparison
Compare FENC & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | SEVN |
|---|---|---|
| Founded | 1996 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.8M | 190.3M |
| IPO Year | 2010 | 2008 |
Fundamental Metrics
Financial Performance| Metric | FENC | SEVN |
|---|---|---|
| Price | $10.49 | $8.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $14.50 | $10.50 |
| AVG Volume (30 Days) | ★ 248.3K | 150.4K |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 13.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.01 | ★ 0.19 |
| Revenue | ★ $44,642,000.00 | $29,383,000.00 |
| Revenue This Year | $65.12 | $27.75 |
| Revenue Next Year | $41.08 | $4.06 |
| P/E Ratio | $1,031.00 | ★ $43.63 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.65 | $7.90 |
| 52 Week High | $11.31 | $11.44 |
Technical Indicators
Market Signals| Indicator | FENC | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 49.62 |
| Support Level | $7.40 | $8.05 |
| Resistance Level | $11.31 | $8.89 |
| Average True Range (ATR) | 0.54 | 0.23 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 61.64 | 25.60 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.